(Q33330706)

25 July 2017

title

Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer (English)

1 reference

25 July 2017

1 reference

1 reference

1 reference

J B Sørensen

1

1 reference

25 July 2017

L E Stenbygaard

series ordinal

2

1 reference

25 July 2017

P Dombernowsky

series ordinal

3

1 reference

25 July 2017

H H Hansen

series ordinal

4

1 reference

25 July 2017

publication date

1 September 1999

1 reference

25 July 2017

1 reference

25 July 2017

volume

10

1 reference

25 July 2017

issue

9

1 reference

25 July 2017

page(s)

1043-1049

1 reference

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352900990

7 January 2021

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352900990

7 January 2021

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352900990

7 January 2021

Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352900990

7 January 2021

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352900990

7 January 2021

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352900990

7 January 2021

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352900990

7 January 2021

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352900990

7 January 2021

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352900990

7 January 2021

Identifiers

DOI

10.1023/A:1008352900990

1 reference

25 July 2017

1 reference